Importance of surrogate markers in evaluation of antiviral therapy for HIV infection

被引:13
|
作者
Deyton, L
机构
[1] Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
来源
关键词
D O I
10.1001/jama.276.2.159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:159 / 160
页数:2
相关论文
共 50 条
  • [21] CORRELATION BETWEEN SURROGATE MARKERS, VIRAL LOAD, AND DISEASE PROGRESSION IN HIV-1 INFECTION
    LAFEUILLADE, A
    TAMALET, C
    PELLEGRINO, P
    DEMICCO, P
    VIGNOLI, C
    QUILICHINI, R
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (10): : 1028 - 1033
  • [22] HIV resistance to antiviral therapy
    Karmochkine, M
    Descamps, D
    ANNALES DE MEDECINE INTERNE, 1999, 150 (08): : 615 - 622
  • [23] Surrogate markers of infection: interrogation of the immune system
    Chakera, Aron
    Lucas, Andrew
    Lucas, Michaela
    BIOMARKERS IN MEDICINE, 2011, 5 (02) : 131 - 148
  • [24] THE EFFECT OF ANTIVIRAL THERAPY ON THE NATURAL-HISTORY OF HIV-INFECTION - REPLY
    RAGNI, MV
    KINGSLEY, LA
    ZHOU, SJ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (10): : 1065 - 1066
  • [25] Secreted Antiviral Entry Inhibitory (SAVE) Peptides for Gene Therapy of HIV Infection
    Egerer, Lisa
    Volk, Andreas
    Kahle, Joerg
    Kimpel, Janine
    Brauer, Frances
    Hermann, Felix G.
    von Laer, Dorothee
    MOLECULAR THERAPY, 2011, 19 (07) : 1236 - 1244
  • [26] Neurologic manifestations of HIV infection - Using imaging studies and antiviral therapy effectively
    Rachlis, AR
    POSTGRADUATE MEDICINE, 1998, 103 (03) : 147 - +
  • [27] The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment
    Florence, E
    Dreezen, C
    Schrooten, W
    Van Esbroeck, M
    Kestens, L
    Fransen, K
    De Roo, A
    Colebunders, R
    INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (08) : 538 - 542
  • [28] Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients
    Frias, M.
    Berarpour, N.
    Pagano, S.
    Sidibe, J.
    Kamau, F.
    Lecour, S.
    Strijdom, H.
    Thomas, A.
    Vuilleumier, N.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3307 - 3307
  • [29] Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration
    Akbar, Sheikh Mohammad Fazle
    Al-Mahtab, Maumn
    Hiasa, Yoichi
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (06) : 717 - 723
  • [30] Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration
    Sheikh Mohammad Fazle Akbar
    Maumn Al-Mahtab
    Yoichi Hiasa
    Journal of Gastroenterology, 2011, 46 : 717 - 723